Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Interest & Investment Income (2016 - 2025)

Historic Interest & Investment Income for Ironwood Pharmaceuticals (IRWD) over the last 17 years, with Q3 2025 value amounting to $930000.0.

  • Ironwood Pharmaceuticals' Interest & Investment Income fell 1927.08% to $930000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year decrease of 3048.73%. This contributed to the annual value of $4.5 million for FY2024, which is 7644.83% down from last year.
  • Per Ironwood Pharmaceuticals' latest filing, its Interest & Investment Income stood at $930000.0 for Q3 2025, which was down 1927.08% from $818000.0 recorded in Q2 2025.
  • Over the past 5 years, Ironwood Pharmaceuticals' Interest & Investment Income peaked at $8.8 million during Q2 2023, and registered a low of $172000.0 during Q2 2021.
  • For the 5-year period, Ironwood Pharmaceuticals' Interest & Investment Income averaged around $1.9 million, with its median value being $1.0 million (2022).
  • Its Interest & Investment Income has fluctuated over the past 5 years, first surged by 306173.91% in 2023, then crashed by 8436.68% in 2024.
  • Over the past 5 years, Ironwood Pharmaceuticals' Interest & Investment Income (Quarter) stood at $180000.0 in 2021, then skyrocketed by 2925.56% to $5.4 million in 2022, then tumbled by 78.08% to $1.2 million in 2023, then tumbled by 34.84% to $778000.0 in 2024, then rose by 19.54% to $930000.0 in 2025.
  • Its Interest & Investment Income stands at $930000.0 for Q3 2025, versus $818000.0 for Q2 2025 and $869000.0 for Q1 2025.